Literature DB >> 11946017

A study of the secondary structure of ilamycin B(1) by 300 MHz proton magnetic resonance.

Lewis W. Cary1, Tomohisa Takita, Masako Ohnishi.   

Abstract

Entities:  

Year:  1971        PMID： 11946017     DOI： 10.1016/0014-5793(71)80584-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  8 in total

1.  Identification and characterization of a bacterial cytochrome P450 monooxygenase catalyzing the 3-nitration of tyrosine in rufomycin biosynthesis.

Authors:  Hiroya Tomita; Yohei Katsuyama; Hiromichi Minami; Yasuo Ohnishi
Journal:  J Biol Chem       Date:  2017-08-03       Impact factor: 5.157

2.  Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502.

Authors:  Bin Zhou; Gauri Shetye; Yang Yu; Bernard D Santarsiero; Larry L Klein; Cele Abad-Zapatero; Nina M Wolf; Jinhua Cheng; Yingyu Jin; Hanki Lee; Joo-Won Suh; Hyun Lee; Jonathan Bisson; James B McAlpine; Shao-Nong Chen; Sang-Hyun Cho; Scott G Franzblau; Guido F Pauli
Journal:  J Nat Prod       Date:  2020-02-07       Impact factor: 4.050

3.  Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.

Authors:  Bin Zhou; Prabhakar S Achanta; Gauri Shetye; Shao-Nong Chen; Hyun Lee; Ying-Yu Jin; Jinhua Cheng; Mi-Jin Lee; Joo-Won Suh; Sanghyun Cho; Scott G Franzblau; Guido F Pauli; James B McAlpine
Journal:  J Nat Prod       Date:  2021-10-10       Impact factor: 4.050

Review 4.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

5.  Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2.

Authors:  Wenhui Zhou; Huan Fang; Qiuju Wu; Xinye Wang; Rong Liu; Fubin Li; Ji Xiao; Lin Yuan; Zhongmei Zhou; Junying Ma; Lulu Wang; Weiwei Zhao; Hua You; Jianhua Ju; Jing Feng; Ceshi Chen
Journal:  Int J Biol Sci       Date:  2019-06-10       Impact factor: 6.580

Review 6.  Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.

Authors:  Edyta M Grzelak; Mary P Choules; Wei Gao; Geping Cai; Baojie Wan; Yuehong Wang; James B McAlpine; Jinhua Cheng; Yingyu Jin; Hanki Lee; Joo-Won Suh; Guido F Pauli; Scott G Franzblau; Birgit U Jaki; Sanghyun Cho
Journal:  J Antibiot (Tokyo)       Date:  2019-07-11       Impact factor: 2.649

Review 7.  Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.

Authors:  Uli Kazmaier; Lukas Junk
Journal:  Mar Drugs       Date:  2021-08-03       Impact factor: 5.118

8.  Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.

Authors:  Junying Ma; Hongbo Huang; Yunchang Xie; Zhiyong Liu; Jin Zhao; Chunyan Zhang; Yanxi Jia; Yun Zhang; Hua Zhang; Tianyu Zhang; Jianhua Ju
Journal:  Nat Commun       Date:  2017-08-30       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.